Investments
27Portfolio Exits
8Funds
1About Merieux Developpement
Merieux Developpement is an evergreen fund specialized in the healthcare sector, conducting growth and venture capital investments worldwide. Merieux Developpement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers, offering them access to its industry expertise and global network. Merieux Developpement is an affiliate of Institut Merieux, which employs around 13,000 employees worldwide with consolidated revenues exceeding EUR 2.0 billion in 2013. Other companies owned by Institut Merieux include bioMerieux (in vitro diagnostics), Merieux NutriSciences (food safety and nutrition services) and Transgene (immunotherapy).
Merieux Developpement Headquarter Location
17 Rue Bourgelat
Lyon, 69002,
France
+33 4 78 87 37 00
Expert Collections containing Merieux Developpement
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Merieux Developpement in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Merieux Developpement News
Mar 1, 2018
Inscripta Raises $55.5M For Gene Editing Tools Pleasanton, California- and Boulder, Colorado-based Inscripta has received $55.5M in a Series C funding, the company said this week, led by Merieux Developpement and Paladin Capital Group, and also included Venrock, Foresite, Spruce, and NanoDimension. Inscripta, which develops gene editing tools, said the new funding comes in preparation for expansion of its platform, and commercial launch. More information »
Merieux Developpement Investments
27 Investments
Merieux Developpement has made 27 investments. Their latest investment was in Keranova as part of their Series B on September 9, 2019.
Merieux Developpement Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/10/2019 | Series B | Keranova | $26.51M | No | Financiere Arbevel, Supernova Invest, Tourrette Investissements, and Undisclosed Investors | 1 |
5/28/2019 | Seed | Waoup | $2.79M | Yes | 1 | |
4/4/2019 | Series C - IV | Inscripta | $20M | No | 5 | |
12/19/2018 | Series C - III | |||||
3/9/2018 | Series C - IV |
Date | 9/10/2019 | 5/28/2019 | 4/4/2019 | 12/19/2018 | 3/9/2018 |
|---|---|---|---|---|---|
Round | Series B | Seed | Series C - IV | Series C - III | Series C - IV |
Company | Keranova | Waoup | Inscripta | ||
Amount | $26.51M | $2.79M | $20M | ||
New? | No | Yes | No | ||
Co-Investors | Financiere Arbevel, Supernova Invest, Tourrette Investissements, and Undisclosed Investors | ||||
Sources | 1 | 1 | 5 |
Merieux Developpement Portfolio Exits
8 Portfolio Exits
Merieux Developpement has 8 portfolio exits. Their latest portfolio exit was Ivantis on November 08, 2021.
Merieux Developpement Acquisitions
2 Acquisitions
Merieux Developpement acquired 2 companies. Their latest acquisition was STIPlastics on January 18, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/18/2018 | Acq - Fin - II | 2 | ||||
3/21/2016 |
Date | 1/18/2018 | 3/21/2016 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin - II | |
Sources | 2 |
Merieux Developpement Fund History
1 Fund History
Merieux Developpement has 1 fund, including Merieux Developpement II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
Merieux Developpement II | $188.35M | 1 |
Closing Date | |
|---|---|
Fund | Merieux Developpement II |
Fund Type | |
Status | |
Amount | $188.35M |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.